Patents Assigned to CytoPherx, Inc
  • Selective cytopheresis devices and related methods thereof
    Patent number: 9498566
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: November 22, 2016
    Assignees: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 9341626
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: May 17, 2016
    Assignees: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 9128093
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: September 8, 2015
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, CYTOPHERX, INC.
    Inventors: H. David Humes, Deborah Buffington
  • Methods for enhanced propagation of cells
    Patent number: 9029144
    Abstract: The present invention relates generally to methods for the isolation and propagation of cells. For example, embodiments of the present invention relate to isolation and propagation methods for the manufacture of a large number of cells for use, for example, in biotherapeutic devices, such as devices for renal replacement therapy for the treatment of acute renal failure (ARF), acute tubular necrosis (ATN), multi-organ failure (MOF), sepsis, cardiorenal syndrome (CRS) and end-stage renal disease (ESRD).
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: May 12, 2015
    Assignees: Innovative Bio Therapies, Inc., CytoPherx, Inc.
    Inventors: Mark Szczypka, Evangelos Tziampazis, Angela J. Westover
  • CYTOPHERESIS CARTRIDGES AND USE THEREOF
    Publication number: 20130288370
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions within a subject and to related methods. More particularly, the invention relates to a cytopheretic cartridge that includes a housing and, disposed within the housing, a solid support capable of sequestering activated leukocytes and/or platelets.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 31, 2013
    Applicant: CYTOPHERX, INC.
    Inventors: H. David Humes, Deborah Buffington, Christopher J. Pino
  • Selective cytopheresis devices and related methods thereof
    Patent number: 8430832
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 30, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 8425445
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 23, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 8425447
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: April 23, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods
    Patent number: 8425446
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 23, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 8409126
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 2, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20120323224
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20120322138
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20120277720
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 25, 2012
    Publication date: November 1, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20120258011
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 25, 2012
    Publication date: October 11, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 8251941
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: August 28, 2012
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Medical device connector
    Patent number: D629893
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: December 28, 2010
    Assignee: CytoPherx, Inc
    Inventor: H. David Humes
  • Medical device connector
    Patent number: D630318
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: January 4, 2011
    Assignee: CytoPherx, Inc.
    Inventor: Cheryl J. Goodwin
  • Medical device connector
    Patent number: D630319
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: January 4, 2011
    Assignee: CytoPherx, Inc
    Inventor: H. David Humes